Stryker Corporation $SYK Shares Acquired by DNB Asset Management AS

DNB Asset Management AS increased its holdings in Stryker Corporation (NYSE:SYK) by 3.3% during the 4th quarter, HoldingsChannel reports. The fund owned 69,674 shares of the medical technology company’s stock after acquiring an additional 2,217 shares during the quarter. DNB Asset Management AS’s holdings in Stryker were worth $24,488,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. United Financial Planning Group LLC acquired a new position in shares of Stryker in the third quarter worth about $27,000. CGC Financial Services LLC acquired a new position in shares of Stryker in the fourth quarter worth about $29,000. Strive Asset Management LLC acquired a new position in shares of Stryker in the third quarter worth about $30,000. ANTIPODES PARTNERS Ltd acquired a new position in shares of Stryker in the third quarter worth about $34,000. Finally, Copia Wealth Management raised its stake in Stryker by 181.6% during the third quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock valued at $40,000 after buying an additional 69 shares in the last quarter. Institutional investors and hedge funds own 77.09% of the company’s stock.

Stryker Stock Performance

Shares of SYK stock opened at $306.74 on Friday. Stryker Corporation has a 12-month low of $281.00 and a 12-month high of $404.87. The firm has a market capitalization of $117.59 billion, a price-to-earnings ratio of 35.50, a price-to-earnings-growth ratio of 1.93 and a beta of 0.80. The business has a 50 day simple moving average of $329.68 and a 200 day simple moving average of $351.73. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The business had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period last year, the company earned $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, equities research analysts anticipate that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s dividend payout ratio (DPR) is presently 40.74%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Canaccord Genuity Group cut their price objective on Stryker from $435.00 to $400.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. William Blair restated an “outperform” rating on shares of Stryker in a research note on Thursday, March 5th. Piper Sandler restated an “overweight” rating on shares of Stryker in a research note on Tuesday, January 27th. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Stryker in a research note on Friday, May 1st. Finally, Barclays cut their price objective on Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Sixteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $395.48.

Insider Transactions at Stryker

In other Stryker news, VP M Kathryn Fink sold 5,220 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $283.85, for a total transaction of $1,481,697.00. Following the completion of the transaction, the vice president directly owned 13,137 shares of the company’s stock, valued at approximately $3,728,937.45. This trade represents a 28.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 4.60% of the company’s stock.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.